GOLDMAN SACHS GROUP INC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$130,193
-52.2%
17,336
-43.8%
0.00%
Q2 2023$272,247
+57.7%
30,832
+48.6%
0.00%
Q1 2023$172,648
-14.3%
20,751
-1.1%
0.00%
Q4 2022$201,456
+259.7%
20,985
+109.2%
0.00%
Q2 2022$56,000
-23.3%
10,029
-23.3%
0.00%
Q1 2022$73,000
+23.7%
13,080
-2.7%
0.00%
Q4 2021$59,000
-53.5%
13,448
+0.1%
0.00%
Q3 2021$127,000
+29.6%
13,432
+0.3%
0.00%
Q2 2021$98,000
-25.2%
13,398
-36.4%
0.00%
Q1 2021$131,000
-28.8%
21,057
-14.6%
0.00%
Q4 2020$184,000
+22.7%
24,671
-0.5%
0.00%
Q3 2020$150,000
-41.2%
24,800
-18.9%
0.00%
Q2 2020$255,000
+203.6%
30,561
+114.9%
0.00%
Q1 2020$84,000
-8.7%
14,2240.0%0.00%
Q4 2019$92,000
+7.0%
14,224
+36.3%
0.00%
Q3 2018$86,000
-51.4%
10,438
-38.6%
0.00%
Q2 2018$177,000
-18.8%
16,990
-5.6%
0.00%
Q1 2018$218,00017,9980.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders